000140686 001__ 140686
000140686 005__ 20240321220845.0
000140686 0247_ $$2doi$$a10.3233/JAD-181088
000140686 0247_ $$2pmid$$apmid:30909232
000140686 0247_ $$2ISSN$$a1387-2877
000140686 0247_ $$2ISSN$$a1875-8908
000140686 0247_ $$2altmetric$$aaltmetric:58068069
000140686 037__ $$aDZNE-2020-07008
000140686 041__ $$aEnglish
000140686 082__ $$a610
000140686 1001_ $$0P:(DE-HGF)0$$aAlexopoulos, Panagiotis$$b0$$eCorresponding author
000140686 245__ $$aPlasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia.
000140686 260__ $$aAmsterdam$$bIOS Press$$c2019
000140686 264_1 $$2Crossref$$3print$$bIOS Press$$c2019-05-07
000140686 3367_ $$2DRIVER$$aarticle
000140686 3367_ $$2DataCite$$aOutput Types/Journal article
000140686 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1710935708_2067
000140686 3367_ $$2BibTeX$$aARTICLE
000140686 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000140686 3367_ $$00$$2EndNote$$aJournal Article
000140686 520__ $$aCost- and time-effective markers of Alzheimer’s disease (AD), reliable and feasible at the population level are urgently needed. Soluble amyloid-β protein precursor β (sAβPPβ) in plasma has attracted scientific attention as a potential AD biomarker candidate. Here we report that plasma sAβPPβ levels in patients with AD dementia and typical for AD cerebrospinal fluid (CSF) biomarker profiles (N = 33) are significantly lower (p < 0.01) than those of cognitively healthy elderly individuals without AD (N = 39), while CSF sAβPPβ levels did not differ between the studied groups. This provides further evidence for the potential of sAβPPβ in plasma as an AD biomarker candidate.
000140686 536__ $$0G:(DE-HGF)POF3-344$$a344 - Clinical and Health Care Research (POF3-344)$$cPOF3-344$$fPOF III$$x0
000140686 588__ $$aDataset connected to CrossRef, PubMed,
000140686 650_2 $$2MeSH$$aAged
000140686 650_2 $$2MeSH$$aAlzheimer Disease: blood
000140686 650_2 $$2MeSH$$aAlzheimer Disease: cerebrospinal fluid
000140686 650_2 $$2MeSH$$aAlzheimer Disease: diagnosis
000140686 650_2 $$2MeSH$$aAmyloid beta-Protein Precursor: blood
000140686 650_2 $$2MeSH$$aAmyloid beta-Protein Precursor: cerebrospinal fluid
000140686 650_2 $$2MeSH$$aBiomarkers: blood
000140686 650_2 $$2MeSH$$aBiomarkers: cerebrospinal fluid
000140686 650_2 $$2MeSH$$aDementia: blood
000140686 650_2 $$2MeSH$$aDementia: diagnosis
000140686 650_2 $$2MeSH$$aFemale
000140686 650_2 $$2MeSH$$aHumans
000140686 650_2 $$2MeSH$$aMale
000140686 650_2 $$2MeSH$$aMiddle Aged
000140686 650_2 $$2MeSH$$atau Proteins: cerebrospinal fluid
000140686 7001_ $$aThierjung, Nathalie$$b1
000140686 7001_ $$aEconomou, Polychronis$$b2
000140686 7001_ $$aWerle, Lukas$$b3
000140686 7001_ $$aBuhl, Felix$$b4
000140686 7001_ $$aKagerbauer, Simone$$b5
000140686 7001_ $$aPapanastasiou, Anastasios D$$b6
000140686 7001_ $$aGrimmer, Timo$$b7
000140686 7001_ $$aGourzis, Philippos$$b8
000140686 7001_ $$aBerthele, Achim$$b9
000140686 7001_ $$aHemmer, Bernhard$$b10
000140686 7001_ $$aKübler, Hubert$$b11
000140686 7001_ $$aMartin, Jan$$b12
000140686 7001_ $$aPolitis, Antonios$$b13
000140686 7001_ $$0P:(DE-2719)2812234$$aPerneczky, Robert$$b14$$eLast author$$udzne
000140686 77318 $$2Crossref$$3journal-article$$a10.3233/jad-181088$$b : IOS Press, 2019-05-07$$n1$$p83-90$$tJournal of Alzheimer's Disease$$v69$$x1387-2877$$y2019
000140686 773__ $$0PERI:(DE-600)2070772-1$$a10.3233/JAD-181088$$gVol. 69, no. 1, p. 83 - 90$$n1$$p83-90$$q69:1<83 - 90$$tJournal of Alzheimer's disease$$v69$$x1387-2877$$y2019
000140686 8564_ $$uhttps://pub.dzne.de/record/140686/files/DZNE-2020-07008_Restricted.pdf
000140686 8564_ $$uhttps://pub.dzne.de/record/140686/files/DZNE-2020-07008_Restricted.pdf?subformat=pdfa$$xpdfa
000140686 909CO $$ooai:pub.dzne.de:140686$$pVDB
000140686 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812234$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b14$$kDZNE
000140686 9131_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x0
000140686 9141_ $$y2019
000140686 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-18
000140686 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-18
000140686 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-18
000140686 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-18
000140686 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-18
000140686 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ ALZHEIMERS DIS : 2021$$d2022-11-18
000140686 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-18
000140686 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-18
000140686 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-18
000140686 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-18
000140686 9201_ $$0I:(DE-2719)1111016$$kAG Levin$$lClinical Neurodegeneration$$x0
000140686 980__ $$ajournal
000140686 980__ $$aVDB
000140686 980__ $$aI:(DE-2719)1111016
000140686 980__ $$aUNRESTRICTED
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1002/ana.22628$$o10.1002/ana.22628
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/S1474-4422(14)70090-0$$o10.1016/S1474-4422(14)70090-0
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.jalz.2011.03.005$$o10.1016/j.jalz.2011.03.005
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.jalz.2018.02.018$$o10.1016/j.jalz.2018.02.018
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/978-1-4939-7674-4_6$$o10.1007/978-1-4939-7674-4_6
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1159/000488481$$o10.1159/000488481
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3233/ADR-170013$$o10.3233/ADR-170013
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/S1474-4422(16)30040-0$$o10.1016/S1474-4422(16)30040-0
000140686 999C5 $$2Crossref$$oRitchie 2017$$y2017
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1093/brain/awv181$$o10.1093/brain/awv181
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3233/JAD-121549$$o10.3233/JAD-121549
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.molmed.2013.10.001$$o10.1016/j.molmed.2013.10.001
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.jalz.2016.09.014$$o10.1016/j.jalz.2016.09.014
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1001/archneurol.2011.1841$$o10.1001/archneurol.2011.1841
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/S1474-4422(16)00070-3$$o10.1016/S1474-4422(16)00070-3
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1038/nature25456$$o10.1038/nature25456
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.15252/emmm.201708763$$o10.15252/emmm.201708763
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1038/tp.2013.11$$o10.1038/tp.2013.11
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.brainres.2013.03.019$$o10.1016/j.brainres.2013.03.019
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s12017-012-8171-4$$o10.1007/s12017-012-8171-4
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3233/JAD-2011-110857$$o10.3233/JAD-2011-110857
000140686 999C5 $$2Crossref$$oMulugeta 2011$$y2011
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1111/ncn3.12195$$o10.1111/ncn3.12195
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1186/s40364-017-0108-5$$o10.1186/s40364-017-0108-5
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.jalz.2013.09.006$$o10.1016/j.jalz.2013.09.006
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s00406-017-0815-9$$o10.1007/s00406-017-0815-9
000140686 999C5 $$2Crossref$$oIllán-Gala 2018$$y2018
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s00406-015-0628-7$$o10.1007/s00406-015-0628-7
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3233/JAD-122329$$o10.3233/JAD-122329
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1111/j.1471-4159.1993.tb09823.x$$o10.1111/j.1471-4159.1993.tb09823.x
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3109/13506120009146438$$o10.3109/13506120009146438
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.52.8.1555$$o10.1212/WNL.52.8.1555
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/978-1-4939-7674-4_12$$o10.1007/978-1-4939-7674-4_12
000140686 999C5 $$2Crossref$$oWerle Lösliches Amyloidvorläuferprotein Beta als Biomarker für die Alzheimer-Krankheit 2015$$tLösliches Amyloidvorläuferprotein Beta als Biomarker für die Alzheimer-Krankheit$$y2015
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3233/JAD-160176$$o10.3233/JAD-160176
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1186/s13195-018-0411-x$$o10.1186/s13195-018-0411-x
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/0140-6736(91)92823-K$$o10.1016/0140-6736(91)92823-K
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.2307/1907382$$o10.2307/1907382
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1002/jnr.22618$$o10.1002/jnr.22618
000140686 999C5 $$2Crossref$$o
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1038/nrneurol.2017.111$$o10.1038/nrneurol.2017.111
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s12035-014-8694-9$$o10.1007/s12035-014-8694-9
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1001/archneur.57.1.100$$o10.1001/archneur.57.1.100
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1126/science.1197623$$o10.1126/science.1197623
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.3233/JAD-170784$$o10.3233/JAD-170784
000140686 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.jns.2018.06.006$$o10.1016/j.jns.2018.06.006